BioCryst Pharmaceuticals, Inc. (BMV:BCRX)

BioCryst Pharmaceuticals Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Cap	28,108	29,161	22,919	40,112	47,477	24,504
Market Cap Growth	-8.22%	27.23%	-42.86%	-15.51%	93.75%	147.90%
Enterprise Value	36,989	38,790	31,419	45,965	49,036	24,094
PE Ratio	-	-17.49	-5.08	-8.63	-13.45	-6.83
Forward PE	13.57	-	-	-	-	-
PS Ratio	2.67	3.48	3.72	7.97	16.25	73.98
PB Ratio	-3.54	-3.30	-2.71	-7.32	-23.87	-68.41
P/TBV Ratio	-80.34	-3.27	-2.53	-7.24	-23.19	-64.69
P/FCF Ratio	94.57	-29.51	-12.67	-13.23	-17.66	-9.72
P/OCF Ratio	88.63	-30.15	-12.96	-13.33	-17.96	-9.75
EV/Sales Ratio	3.58	4.63	5.10	9.13	16.78	72.75
EV/EBITDA Ratio	32.86	-1608.36	-16.56	-16.82	-14.90	-7.45
EV/EBIT Ratio	35.96	-820.31	-16.29	-16.65	-14.84	-7.41
EV/FCF Ratio	124.45	-39.25	-17.36	-15.16	-18.24	-9.55
Debt / Equity Ratio	-1.75	-1.76	-1.86	-2.51	-5.53	-14.45
Debt / EBITDA Ratio	13.31	-648.74	-8.32	-5.05	-3.36	-1.61
Debt / FCF Ratio	46.88	-15.83	-8.72	-4.55	-4.11	-2.06
Asset Turnover	1.18	0.89	0.62	0.48	0.34	0.07
Inventory Turnover	2.54	0.67	0.16	0.30	0.63	0.44
Quick Ratio	1.98	2.49	2.97	4.50	5.18	2.92
Current Ratio	2.25	2.63	3.31	4.90	5.46	3.06
Return on Equity (ROE)	7.96%	19.08%	60.40%	123.07%	291.59%	-1925.37%
Return on Assets (ROA)	12.70%	-0.52%	-19.47%	-26.38%	-38.99%	-68.53%
Return on Capital (ROIC)	53.71%	-3.44%	-246.38%	-481.47%	-403.55%	-265.12%
Return on Capital Employed (ROCE)	17.79%	-0.73%	-25.56%	-31.96%	-49.82%	-112.02%
Earnings Yield	-2.40%	-5.72%	-19.70%	-11.59%	-7.44%	-14.63%
FCF Yield	1.06%	-3.39%	-7.89%	-7.56%	-5.66%	-10.29%
Buyback Yield / Dilution	-0.09%	0.26%	-0.53%	-0.69%	-2.58%	-8.39%
Total Shareholder Return	-	0.26%	-0.53%	-0.69%	-2.58%	-8.39%

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.